INMIND
Imaging of Neuroinflammation in Neurodegenerative Diseases
| Coordinatore | WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
Organization address
address: SCHLOSSPLATZ 2 contact info |
| Nazionalità Coordinatore | Germany [DE] |
| Sito del progetto | http://www.uni-muenster.de/InMind/ |
| Totale costo | 24˙909˙008 € |
| EC contributo | 11˙998˙478 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2011-two-stage |
| Funding Scheme | CP-IP |
| Anno di inizio | 2012 |
| Periodo (anno-mese-giorno) | 2012-03-01 - 2017-02-28 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
Organization address
address: SCHLOSSPLATZ 2 contact info |
DE (MUENSTER) | coordinator | 1˙895˙000.00 |
| 2 |
KATHOLIEKE UNIVERSITEIT LEUVEN
Organization address
address: Oude Markt 13 contact info |
BE (LEUVEN) | participant | 632˙000.00 |
| 3 |
THE UNIVERSITY OF MANCHESTER
Organization address
address: OXFORD ROAD contact info |
UK (MANCHESTER) | participant | 625˙617.00 |
| 4 |
KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
SE (STOCKHOLM) | participant | 615˙000.00 |
| 5 |
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD contact info |
UK (LONDON) | participant | 576˙000.00 |
| 6 |
VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG
Organization address
address: De Boelelaan 1105 contact info |
NL (AMSTERDAM) | participant | 495˙000.00 |
| 7 |
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
Organization address
address: RUE LEBLANC 25 contact info |
FR (PARIS 15) | participant | 440˙000.00 |
| 8 |
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Organization address
address: CALLE ROSSELLO 149 PUERTA BJS contact info |
ES (BARCELONA) | participant | 440˙000.00 |
| 9 |
PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG
Organization address
address: STRUBERGASSE 21 contact info |
AT (SALZBURG) | participant | 440˙000.00 |
| 10 |
UNIVERSITA DEGLI STUDI DI MILANO
Organization address
address: Via Festa Del Perdono 7 contact info |
IT (MILANO) | participant | 440˙000.00 |
| 11 |
UNIVERSITEIT ANTWERPEN
Organization address
address: PRINSSTRAAT 13 contact info |
BE (ANTWERPEN) | participant | 440˙000.00 |
| 12 |
UNIVERSITA DEGLI STUDI DI TORINO
Organization address
address: Via Giuseppe Verdi 8 contact info |
IT (TORINO) | participant | 438˙500.00 |
| 13 |
UNIVERSITY OF SOUTHAMPTON
Organization address
address: Highfield contact info |
UK (SOUTHAMPTON) | participant | 437˙000.00 |
| 14 |
REGION HOVEDSTADEN
Organization address
address: KONGENS VAENGE 2 contact info |
DK (HILLEROD) | participant | 427˙000.00 |
| 15 |
UNIVERSITA VITA-SALUTE SAN RAFFAELE
Organization address
address: Via Olgettina 58 contact info |
IT (MILANO) | participant | 427˙000.00 |
| 16 |
UNIVERSITE FRANCOIS RABELAIS DE TOURS
Organization address
address: RUE DU PLAT D ETAIN 60 contact info |
FR (TOURS) | participant | 404˙000.00 |
| 17 |
VARSINAIS-SUOMEN SAIRAANHOITOPIIRIN KUNTAYHTYMA
Organization address
address: KIINAMYLLYNKATU 4-8 contact info |
FI (TURKU) | participant | 395˙600.00 |
| 18 |
UNIVERSITAETSKLINIKUM BONN
Organization address
address: Sigmund-Freud-Strasse 25 contact info |
DE (BONN) | participant | 380˙000.00 |
| 19 |
Pharmidex Pharmaceutical Services Limited
Organization address
address: HANOVER STREET 14 FLOOR 3 contact info |
UK (LONDON) | participant | 367˙488.00 |
| 20 |
TOP (TRANSGENIC OPERATIVE PRODUCTS) S.R.L.
Organization address
address: VIA EINSTEIN contact info |
IT (LODI LO) | participant | 344˙000.00 |
| 21 |
CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Piazzale Aldo Moro 7 contact info |
IT (ROMA) | participant | 277˙333.00 |
| 22 |
Mediso Orvosi Berendezes Fejleszto es Szerviz Kft.
Organization address
address: ALSOTOROKVESZ 14 contact info |
HU (BUDAPEST) | participant | 253˙440.00 |
| 23 |
CYCLOTRON VRIJE UNIVERSITEIT BV
Organization address
address: DE BOELELAAN 1081 contact info |
NL (AMSTERDAM) | participant | 244˙500.00 |
| 24 |
CAGE CHEMICALS SRL
Organization address
address: VIA BOVIO 6 contact info |
IT (NOVARA) | participant | 194˙000.00 |
| 25 |
ANIONA APS
Organization address
address: Pederstrupvej 93 contact info |
DK (BALLERUP) | participant | 180˙000.00 |
| 26 |
SEMMELWEIS EGYETEM
Organization address
address: Ulloi ut 26 contact info |
HU (BUDAPEST) | participant | 180˙000.00 |
| 27 |
UNIVERSITE PARIS DESCARTES
Organization address
address: Rue de l'Ecole de Medecine 12 contact info |
FR (PARIS) | participant | 10˙000.00 |
| 28 |
NEUROSEARCH AS
Organization address
address: Pederstrupvej 93 contact info |
DK (BALLERUP) | participant | 0.00 |
| 29 |
THE UNIVERSITY OF SYDNEY
Organization address
address: The University of Sydney contact info |
AU (SYDNEY) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The goal of this proposal (INMiND) is to carry out collaborative research on molecular mechanisms that link neuroinflammation with neurodegeneration in order to identify novel biological targets for activated microglia, which may serve for both diagnostic and therapeutic purposes, and to translate this knowledge into the clinic. The general objectives of INMiND are:
(i) to identify novel mechanisms of regulation and function of microglia under various conditions (inflammatory stimuli; neurodegenerative and -regenerative model systems); (ii) to identify and implement new targets for activated microglia, which may serve for diagnostic (imaging) and therapeutic purposes; (iii) to design new molecular probes (tracers) for these novel targets and to implement and validate them in in vivo model systems and patients; (iv) to image and quantify modulated microglia activity in patients undergoing immune therapy for cognitive impairment and relate findings to clinical outcome.
Within INMiND we bring together a group of excellent scientists with a proven background in efficiently accomplishing common scientific goals (FP6 project DiMI, www.dimi.eu), who belong to highly complementary fields of research (from genome-oriented to imaging scientists and clinicians), and who are dedicated to formulate novel image-guided therapeutic strategies for neuroinflammation related neurodegenerative diseases. The strength of this proposal is that, across Europe, it will coordinate research and training activities related to neuroinflammation, neurodegeneration/-regeneration and imaging with special emphasis on translating basic mechanisms into clinical applications that will provide health benefits for our aging population. With its intellectual excellence and its crucial mass the INMiND consortium will play a major role in the European Research Area and will gain European leadership in the creation of new image-guided therapy paradigms in patients with neurodegenerative diseases.'
Introduzione (Teaser)
Patients suffering from neurodegenerative diseases (NDs) such as Alzheimer's, Parkinson's and multiple sclerosis present with devastating cognitive disabilities. Through the development of novel biomarkers and imaging tools, a large European consortium aims to improve the diagnosis and treatment outcomes for these patients.
Altri progetti dello stesso programma (FP7-HEALTH)
MYASTERIX (2013)
"Clinical safety, immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicking antigen receptors on autoimmune B and T cells associated with myasthenia gravis"
Read More